Glucose Metabolism Disorders (Including Diabetes Mellitus) Clinical Trials

7 recruiting

Glucose Metabolism Disorders (Including Diabetes Mellitus) Trials at a Glance

7 actively recruiting trials for glucose metabolism disorders (including diabetes mellitus) are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Baltimore, Chicago, and Gatineau. Lead sponsors running glucose metabolism disorders (including diabetes mellitus) studies include Gaia AG, Maastricht University Medical Center, and Anne-Sophie Brazeau.

Browse glucose metabolism disorders (including diabetes mellitus) trials by phase

Treatments under study

About Glucose Metabolism Disorders (Including Diabetes Mellitus) Clinical Trials

Looking for clinical trials for Glucose Metabolism Disorders (Including Diabetes Mellitus)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Glucose Metabolism Disorders (Including Diabetes Mellitus) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Glucose Metabolism Disorders (Including Diabetes Mellitus) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1Phase 2

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Metabolic DiseaseDiabetes Mellitus, Type 1Type 1 Diabetes+14 more
Otsuka Pharmaceutical Factory, Inc.13 enrolled1 locationNCT06575426
Recruiting
Not Applicable

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

Diabetes MellitusMetabolic DiseaseDiabetes Mellitus, Type 1+4 more
Anne-Sophie Brazeau200 enrolled4 locationsNCT05910840
Recruiting
Not Applicable

The Effect of Chlorhexidine Mouthwash on Postprandial Glucose Response in Healthy Individuals

Glucose Metabolism Disorders (Including Diabetes Mellitus)
University of Plymouth45 enrolled1 locationNCT07172009
Recruiting

Glucose Variability and Cognition in Prediabetes

Cognitive DeclineGlucose Metabolism Disorders (Including Diabetes Mellitus)Functional Status
University of Maryland, Baltimore30 enrolled1 locationNCT04201600
Recruiting
Not Applicable

Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM

Metabolic DiseaseDiabetes Mellitus, Type 2Endocrine System Diseases+1 more
Gaia AG250 enrolled1 locationNCT06529965
Recruiting
Not Applicable

Acute Microbial Switch

HyperinsulinismInsulin SensitivityGlucose Metabolism Disorders (Including Diabetes Mellitus)
Maastricht University Medical Center28 enrolled2 locationsNCT05764200
Recruiting
Not Applicable

The Role of Oxytocin in Regulating Blood Glucose

Glucose Metabolism Disorders (Including Diabetes Mellitus)
University Hospital, Gentofte, Copenhagen20 enrolled1 locationNCT06334172